Neogen Corporation (NEOG)
USD 11.64
(-4.04%)
USD 11.64
(-4.04%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 4.58 Billion USD | -0.12% |
| 2023 | 4.55 Billion USD | 358.69% |
| 2022 | 992.92 Million USD | 7.9% |
| 2021 | 920.19 Million USD | 15.43% |
| 2020 | 797.18 Million USD | 14.58% |
| 2019 | 695.74 Million USD | 12.58% |
| 2018 | 618 Million USD | 16.96% |
| 2017 | 528.4 Million USD | 16.98% |
| 2016 | 451.71 Million USD | 15.18% |
| 2015 | 392.18 Million USD | 13.58% |
| 2014 | 345.3 Million USD | 19.38% |
| 2013 | 289.25 Million USD | 14.96% |
| 2012 | 251.6 Million USD | 14.54% |
| 2011 | 219.66 Million USD | 21.88% |
| 2010 | 180.23 Million USD | 26.77% |
| 2009 | 142.17 Million USD | 12.52% |
| 2008 | 126.35 Million USD | 20.02% |
| 2007 | 105.28 Million USD | 19.25% |
| 2006 | 88.29 Million USD | 38.2% |
| 2005 | 63.88 Million USD | 6.52% |
| 2004 | 59.97 Million USD | 24.85% |
| 2003 | 48.03 Million USD | 20.38% |
| 2002 | 39.9 Million USD | 20.84% |
| 2001 | 33.02 Million USD | 11.83% |
| 2000 | 29.52 Million USD | 13.13% |
| 1999 | 26.1 Million USD | 2.76% |
| 1998 | 25.4 Million USD | 9.96% |
| 1997 | 23.1 Million USD | 100.87% |
| 1996 | 11.5 Million USD | 0.0% |
| 1995 | 11.5 Million USD | 26.37% |
| 1994 | 9.1 Million USD | 24.66% |
| 1993 | 7.3 Million USD | -3.95% |
| 1992 | 7.6 Million USD | -10.59% |
| 1991 | 8.5 Million USD | -9.57% |
| 1990 | 9.4 Million USD | 104.35% |
| 1989 | 4.6 Million USD | -11.54% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 4.6 Billion USD | 0.91% |
| 2024 FY | 4.58 Billion USD | 0.65% |
| 2024 Q4 | 4.58 Billion USD | 0.04% |
| 2024 Q3 | 4.58 Billion USD | -0.43% |
| 2024 Q1 | 4.56 Billion USD | 0.15% |
| 2023 FY | 4.55 Billion USD | 358.69% |
| 2023 Q3 | 4.5 Billion USD | -1.15% |
| 2023 Q2 | 4.56 Billion USD | 366.64% |
| 2023 Q1 | 977.4 Million USD | -1.56% |
| 2023 Q4 | 4.55 Billion USD | 1.01% |
| 2022 Q3 | 979.89 Million USD | 1.37% |
| 2022 FY | 992.92 Million USD | 7.9% |
| 2022 Q4 | 992.92 Million USD | 1.33% |
| 2022 Q2 | 966.68 Million USD | 3.71% |
| 2022 Q1 | 932.1 Million USD | 1.29% |
| 2021 Q3 | 880.21 Million USD | 4.09% |
| 2021 Q2 | 845.62 Million USD | 2.93% |
| 2021 FY | 920.19 Million USD | 15.43% |
| 2021 Q1 | 821.59 Million USD | 3.06% |
| 2021 Q4 | 920.19 Million USD | 4.54% |
| 2020 FY | 797.18 Million USD | 14.58% |
| 2020 Q2 | 750.59 Million USD | 4.08% |
| 2020 Q3 | 773.5 Million USD | 3.05% |
| 2020 Q4 | 797.18 Million USD | 3.06% |
| 2020 Q1 | 721.14 Million USD | 3.65% |
| 2019 Q4 | 695.74 Million USD | 3.44% |
| 2019 Q2 | 660.49 Million USD | 3.05% |
| 2019 Q1 | 640.92 Million USD | 3.71% |
| 2019 FY | 695.74 Million USD | 12.58% |
| 2019 Q3 | 672.58 Million USD | 1.83% |
| 2018 Q3 | 595.6 Million USD | 2.51% |
| 2018 Q4 | 618 Million USD | 3.76% |
| 2018 FY | 618 Million USD | 16.96% |
| 2018 Q1 | 547.33 Million USD | 3.58% |
| 2018 Q2 | 581.02 Million USD | 6.16% |
| 2017 Q3 | 507.29 Million USD | 4.1% |
| 2017 Q1 | 468.61 Million USD | 3.74% |
| 2017 FY | 528.4 Million USD | 16.98% |
| 2017 Q2 | 487.31 Million USD | 3.99% |
| 2017 Q4 | 528.4 Million USD | 4.16% |
| 2016 Q2 | 425.78 Million USD | 4.2% |
| 2016 Q1 | 408.6 Million USD | 4.19% |
| 2016 FY | 451.71 Million USD | 15.18% |
| 2016 Q4 | 451.71 Million USD | 4.51% |
| 2016 Q3 | 432.24 Million USD | 1.52% |
| 2015 Q4 | 392.18 Million USD | 3.63% |
| 2015 Q2 | 365.91 Million USD | 2.31% |
| 2015 Q1 | 357.66 Million USD | 3.58% |
| 2015 Q3 | 378.43 Million USD | 3.42% |
| 2015 FY | 392.18 Million USD | 13.58% |
| 2014 Q3 | 330.35 Million USD | 3.33% |
| 2014 Q1 | 308.13 Million USD | 6.53% |
| 2014 FY | 345.3 Million USD | 19.38% |
| 2014 Q2 | 319.71 Million USD | 3.76% |
| 2014 Q4 | 345.3 Million USD | 4.53% |
| 2013 Q3 | 281.02 Million USD | 4.21% |
| 2013 Q4 | 289.25 Million USD | 2.93% |
| 2013 Q2 | 269.67 Million USD | 3.4% |
| 2013 Q1 | 260.79 Million USD | 3.66% |
| 2013 FY | 289.25 Million USD | 14.96% |
| 2012 Q3 | 240.34 Million USD | 2.57% |
| 2012 Q1 | 227.62 Million USD | 3.62% |
| 2012 Q4 | 251.6 Million USD | 4.68% |
| 2012 FY | 251.6 Million USD | 14.54% |
| 2012 Q2 | 234.31 Million USD | 2.94% |
| 2011 FY | 219.66 Million USD | 21.88% |
| 2011 Q4 | 219.66 Million USD | 5.02% |
| 2011 Q3 | 209.15 Million USD | 2.69% |
| 2011 Q2 | 203.67 Million USD | 6.8% |
| 2011 Q1 | 190.71 Million USD | 5.82% |
| 2010 FY | 180.23 Million USD | 26.77% |
| 2010 Q1 | 151.57 Million USD | 6.61% |
| 2010 Q2 | 160.91 Million USD | 6.16% |
| 2010 Q3 | 165.3 Million USD | 2.73% |
| 2010 Q4 | 180.23 Million USD | 9.03% |
| 2009 Q4 | 142.17 Million USD | 1.43% |
| 2009 FY | 142.17 Million USD | 12.52% |
| 2009 Q1 | 133.07 Million USD | 5.31% |
| 2009 Q3 | 140.17 Million USD | 2.36% |
| 2009 Q2 | 136.93 Million USD | 2.91% |
| 2008 Q4 | 126.35 Million USD | 5.46% |
| 2008 Q2 | 114.92 Million USD | 5.6% |
| 2008 Q1 | 108.83 Million USD | 3.37% |
| 2008 FY | 126.35 Million USD | 20.02% |
| 2008 Q3 | 119.81 Million USD | 4.25% |
| 2007 FY | 105.28 Million USD | 19.25% |
| 2007 Q1 | 94.28 Million USD | 6.79% |
| 2007 Q4 | 105.28 Million USD | 5.29% |
| 2007 Q2 | 98.08 Million USD | 4.04% |
| 2007 Q3 | 99.99 Million USD | 1.94% |
| 2006 Q3 | 85.69 Million USD | 23.73% |
| 2006 FY | 88.29 Million USD | 38.2% |
| 2006 Q4 | 88.29 Million USD | 3.03% |
| 2006 Q2 | 69.25 Million USD | 2.3% |
| 2006 Q1 | 67.69 Million USD | 5.97% |
| 2005 Q1 | 60.23 Million USD | 0.43% |
| 2005 Q2 | 63.13 Million USD | 4.81% |
| 2005 Q3 | 62.92 Million USD | -0.34% |
| 2005 Q4 | 63.88 Million USD | 1.53% |
| 2005 FY | 63.88 Million USD | 6.52% |
| 2004 Q4 | 59.97 Million USD | 2.83% |
| 2004 FY | 59.97 Million USD | 24.85% |
| 2004 Q3 | 58.32 Million USD | 7.52% |
| 2004 Q2 | 54.24 Million USD | 12.51% |
| 2004 Q1 | 48.21 Million USD | 0.37% |
| 2003 Q4 | 48.03 Million USD | 9.47% |
| 2003 FY | 48.03 Million USD | 20.38% |
| 2003 Q3 | 43.88 Million USD | 3.34% |
| 2003 Q2 | 42.46 Million USD | 3.4% |
| 2003 Q1 | 41.06 Million USD | 2.91% |
| 2002 Q1 | 34.83 Million USD | 5.5% |
| 2002 FY | 39.9 Million USD | 20.84% |
| 2002 Q2 | 36.48 Million USD | 4.71% |
| 2002 Q3 | 37.46 Million USD | 2.71% |
| 2002 Q4 | 39.9 Million USD | 6.5% |
| 2001 Q1 | 29.33 Million USD | -0.65% |
| 2001 Q4 | 33.02 Million USD | 6.64% |
| 2001 Q3 | 30.96 Million USD | 4.08% |
| 2001 Q2 | 29.75 Million USD | 1.41% |
| 2001 FY | 33.02 Million USD | 11.83% |
| 2000 Q1 | 26.5 Million USD | 1.53% |
| 2000 Q4 | 29.52 Million USD | 8.05% |
| 2000 FY | 29.52 Million USD | 13.13% |
| 2000 Q3 | 27.32 Million USD | 0.47% |
| 2000 Q2 | 27.2 Million USD | 2.64% |
| 1999 FY | 26.1 Million USD | 2.76% |
| 1999 Q4 | 26.1 Million USD | 0.77% |
| 1999 Q3 | 25.9 Million USD | -2.63% |
| 1999 Q2 | 26.6 Million USD | 1.14% |
| 1999 Q1 | 26.3 Million USD | 3.54% |
| 1998 Q1 | 23.8 Million USD | 3.03% |
| 1998 Q4 | 25.4 Million USD | 0.4% |
| 1998 Q3 | 25.3 Million USD | 2.43% |
| 1998 Q2 | 24.7 Million USD | 3.78% |
| 1998 FY | 25.4 Million USD | 9.96% |
| 1997 Q1 | 12.3 Million USD | 6.96% |
| 1997 Q4 | 23.1 Million USD | 2.67% |
| 1997 Q3 | 22.5 Million USD | 2.27% |
| 1997 Q2 | 22 Million USD | 78.86% |
| 1997 FY | 23.1 Million USD | 100.87% |
| 1996 Q3 | 12.3 Million USD | 2.5% |
| 1996 Q4 | 11.5 Million USD | -6.5% |
| 1996 Q2 | 12 Million USD | 3.45% |
| 1996 FY | 11.5 Million USD | 0.0% |
| 1996 Q1 | 11.6 Million USD | 0.87% |
| 1995 Q4 | 11.5 Million USD | 0.0% |
| 1995 FY | 11.5 Million USD | 26.37% |
| 1994 Q2 | 8.9 Million USD | 15.58% |
| 1994 FY | 9.1 Million USD | 24.66% |
| 1994 Q4 | 9.1 Million USD | 0.0% |
| 1994 Q1 | 7.7 Million USD | 5.48% |
| 1993 Q1 | 7.3 Million USD | -3.95% |
| 1993 FY | 7.3 Million USD | -3.95% |
| 1993 Q4 | 7.3 Million USD | 0.0% |
| 1992 Q4 | 7.6 Million USD | 0.0% |
| 1992 FY | 7.6 Million USD | -10.59% |
| 1991 FY | 8.5 Million USD | -9.57% |
| 1991 Q4 | 8.5 Million USD | 0.0% |
| 1990 Q4 | 9.4 Million USD | 0.0% |
| 1990 FY | 9.4 Million USD | 104.35% |
| 1989 FY | 4.6 Million USD | -11.54% |
| 1989 Q4 | 4.6 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bionano Genomics, Inc. | 214.4 Million USD | -2038.094% |
| Prenetics Global Limited | 254.17 Million USD | -1703.577% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -5170.725% |
| CareDx, Inc | 484.61 Million USD | -845.939% |
| Exact Sciences Corporation | 6.47 Billion USD | 29.162% |
| Exagen Inc. | 56.94 Million USD | -7950.295% |
| Inotiv, Inc. | 856.53 Million USD | -435.201% |
| Guardant Health, Inc. | 1.78 Billion USD | -156.611% |
| Biodesix, Inc. | 99.09 Million USD | -4525.979% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -40112.66% |
| Precipio, Inc. | 18.1 Million USD | -25225.452% |
| iSpecimen Inc. | 15.81 Million USD | -28878.572% |
| Natera, Inc. | 1.45 Billion USD | -214.603% |
| Aspira Women's Health Inc. | 6.26 Million USD | -73106.004% |
| Standard BioTools Inc. | 323.06 Million USD | -1318.95% |
| 23andMe Holding Co. | 395.16 Million USD | -1060.056% |
| Castle Biosciences, Inc. | 477.81 Million USD | -859.409% |
| Personalis, Inc. | 225.09 Million USD | -1936.508% |
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -2222.211% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -33479.71% |
| OpGen, Inc. | 1.88 Million USD | -243443.714% |
| T2 Biosystems, Inc. | 34.79 Million USD | -13074.009% |
| Myriad Genetics, Inc. | 1.19 Billion USD | -282.428% |
| ICON Public Limited Company | 16.98 Billion USD | 73.018% |
| NeoGenomics, Inc. | 1.68 Billion USD | -172.667% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -5170.725% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -40.622% |
| RadNet, Inc. | 2.88 Billion USD | -58.803% |
| MDxHealth SA | 129.13 Million USD | -3449.98% |
| Psychemedics Corporation | 13.27 Million USD | -34445.29% |
| Illumina, Inc. | 10.11 Billion USD | 54.662% |
| Check-Cap Ltd. | 25.01 Million USD | -18224.18% |
| Twist Bioscience Corporation | 776.4 Million USD | -490.436% |
| DarioHealth Corp. | 96.38 Million USD | -4655.895% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | -260.076% |
| Sera Prognostics, Inc. | 95.44 Million USD | -4703.135% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -67771.793% |
| OPKO Health, Inc. | 2.01 Billion USD | -127.875% |
| Medpace Holdings, Inc. | 1.65 Billion USD | -176.683% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -33169.509% |
| Prenetics Global Limited | 254.17 Million USD | -1703.577% |
| Mainz Biomed B.V. | 15.4 Million USD | -29649.832% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -55657.842% |
| Trinity Biotech plc | 59.43 Million USD | -7612.896% |
| Neuronetics, Inc. | 115.83 Million USD | -3857.628% |
| Sotera Health Company | 3.13 Billion USD | -46.439% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -55657.842% |